Vanguard Group’s Xeris Biopharma Holdings XERS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $45.8M | Buy |
9,816,937
+1,707,293
| +21% | +$7.97M | ﹤0.01% | 2160 |
|
2025
Q1 | $44.5M | Buy |
8,109,644
+210,581
| +3% | +$1.16M | ﹤0.01% | 2139 |
|
2024
Q4 | $26.8M | Buy |
7,899,063
+133,738
| +2% | +$453K | ﹤0.01% | 2444 |
|
2024
Q3 | $22.1M | Buy |
7,765,325
+108,435
| +1% | +$309K | ﹤0.01% | 2545 |
|
2024
Q2 | $17.2M | Buy |
7,656,890
+50,648
| +0.7% | +$114K | ﹤0.01% | 2646 |
|
2024
Q1 | $16.8M | Buy |
7,606,242
+519,897
| +7% | +$1.15M | ﹤0.01% | 2684 |
|
2023
Q4 | $16.7M | Buy |
7,086,345
+60,181
| +0.9% | +$141K | ﹤0.01% | 2676 |
|
2023
Q3 | $13.1M | Buy |
7,026,164
+74,565
| +1% | +$139K | ﹤0.01% | 2724 |
|
2023
Q2 | $18.2M | Buy |
6,951,599
+110,515
| +2% | +$290K | ﹤0.01% | 2632 |
|
2023
Q1 | $11.2M | Buy |
6,841,084
+243,128
| +4% | +$396K | ﹤0.01% | 2877 |
|
2022
Q4 | $8.78M | Buy |
6,597,956
+88,223
| +1% | +$117K | ﹤0.01% | 3012 |
|
2022
Q3 | $10.2M | Buy |
6,509,733
+216,252
| +3% | +$337K | ﹤0.01% | 2945 |
|
2022
Q2 | $9.69M | Buy |
6,293,481
+1,085,295
| +21% | +$1.67M | ﹤0.01% | 3004 |
|
2022
Q1 | $13.3M | Buy |
5,208,186
+92,563
| +2% | +$237K | ﹤0.01% | 3000 |
|
2021
Q4 | $15M | Buy |
5,115,623
+2,139,443
| +72% | +$6.27M | ﹤0.01% | 2990 |
|
2021
Q3 | $7.29M | Sell |
2,976,180
-4,187
| -0.1% | -$10.3K | ﹤0.01% | 3425 |
|
2021
Q2 | $12.1M | Buy |
2,980,367
+234,322
| +9% | +$954K | ﹤0.01% | 3111 |
|
2021
Q1 | $12.4M | Buy |
2,746,045
+332,997
| +14% | +$1.5M | ﹤0.01% | 3034 |
|
2020
Q4 | $11.9M | Buy |
2,413,048
+187,643
| +8% | +$923K | ﹤0.01% | 2907 |
|
2020
Q3 | $13.2M | Buy |
2,225,405
+58,161
| +3% | +$345K | ﹤0.01% | 2650 |
|
2020
Q2 | $5.77M | Buy |
2,167,244
+475,407
| +28% | +$1.26M | ﹤0.01% | 3034 |
|
2020
Q1 | $3.3M | Buy |
1,691,837
+373,777
| +28% | +$729K | ﹤0.01% | 3151 |
|
2019
Q4 | $9.29M | Buy |
1,318,060
+23,531
| +2% | +$166K | ﹤0.01% | 2893 |
|
2019
Q3 | $12.7M | Buy |
1,294,529
+75,376
| +6% | +$741K | ﹤0.01% | 2703 |
|
2019
Q2 | $13.9M | Buy |
1,219,153
+81,209
| +7% | +$929K | ﹤0.01% | 2680 |
|
2019
Q1 | $11.4M | Buy |
1,137,944
+809,635
| +247% | +$8.13M | ﹤0.01% | 2756 |
|
2018
Q4 | $5.58M | Buy |
328,309
+73,245
| +29% | +$1.25M | ﹤0.01% | 3039 |
|
2018
Q3 | $4.48M | Buy |
255,064
+230,064
| +920% | +$4.04M | ﹤0.01% | 3276 |
|
2018
Q2 | $474K | Buy |
+25,000
| New | +$474K | ﹤0.01% | 3830 |
|